- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 15.2494 ↓ -0.24%
[as on 6 March, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of quant Healthcare Fund - Growth Option - Direct Plan and its peers as on 6 March, 2026
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| quant Healthcare Fund - Growth Option - Direct Plan | -2.1% | -0.24% | -2.57% | 1.51% | -2.25% | 7.96% | - | - | - | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -6.88% | -0.48% | -2.33% | -2.98% | -7.15% | 0.58% | 13.01% | 15.94% | 15.17% | 15.96% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -5.68% | -1.18% | -3.5% | -3.99% | -6.28% | 8.33% | 13.66% | 11.75% | 13.69% | 13.62% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 2.01% | -0.09% | -0.62% | 4.31% | 0.05% | 8.52% | 27.17% | 18.41% | 21.54% | 13.29% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | -4.22% | -0.61% | -3.2% | -3.17% | -3.24% | 8.99% | 20.54% | 19.96% | 19.54% | 17.48% |
| SBI PSU Fund - DIRECT PLAN - GROWTH | 6.09% | -0.46% | -2.93% | 1.91% | 8.44% | 29.55% | 33.66% | 28.09% | 21.61% | 17.17% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | - | - | - | - | - | - | - | - | 32.34% | -4.87% |
Discrete returns (monthly)
| Month | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 |
|---|
| Returns | 5.45% | 2.45% | -2.43% | -0.14% | 0.25% | 1.27% | -0.5% | -1.78% | -5.07% | 2.58% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|
| Returns | -7.94% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 78.95% |
6.21% (Arbitrage: 0.00%) |
0.00% |
0.00% |
-3.65% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sequent Scientific Limited | SEQUENT (INE807F01027) | Pharmaceuticals & Biotechnology | 8.26% |
| Zydus Wellness Ltd | ZYDUSWELL (INE768C01028) | Food Products | 7.97% |
| Aster DM Healthcare Limited | ASTERDM (INE914M01019) | Healthcare Services | 7.89% |
| SMS Pharmaceuticals Limited | SMSPHARMA (INE812G01025) | Pharmaceuticals & Biotechnology | 6.53% |
| Pfizer Ltd | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 6.51% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 6.45% |
| ANTHEM BIOSCIENCES LIMITED | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 6.17% |
| Adani Enterprises Limited | ADANIENT (INE423A01024) | Metals & Minerals Trading | 6.14% |
| Alivus Life Sciences | ALIVUS (INE03Q201024) | Pharmaceuticals & Biotechnology | 5.80% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 3.58% |
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 3.40% |
| Concord Biotech Limited | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 3.14% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 2.91% |
| Godrej Properties Limited | GODREJPROP (INE484J01027) | Realty | 2.80% |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.41% |
Debt
| Name | Rating | Weight % |
|---|
| 91 Days Treasury Bill 18-Dec-2025 | N.A. | 1.81% |
| 91 Days Treasury Bill 20-Nov-2025 | N.A. | 0.78% |
| 91 Days Treasury Bill 28-Nov-2025 | N.A. | 0.78% |
| 91 Days Treasury Bill 04-Dec-2025 | N.A. | 0.78% |
| 91 Days Treasury Bill 02-Jan-2026 | N.A. | 0.77% |
| 91 Days Treasury Bill 15-Jan-2026 | N.A. | 0.77% |
| 91 Days Treasury Bill 23-Jan-2026 | N.A. | 0.51% |
Portfolio data is as on date 31 October, 2025
NAV history
quant Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history
| Date | NAV |
|---|
| 6 March, 2026 | 15.2494 |
| 5 March, 2026 | 15.2868 |
| 4 March, 2026 | 15.1463 |
| 2 March, 2026 | 15.349 |
| 27 February, 2026 | 15.6509 |
| 26 February, 2026 | 15.8697 |
| 25 February, 2026 | 15.7876 |
| 24 February, 2026 | 15.5827 |
| 23 February, 2026 | 15.6373 |
| 20 February, 2026 | 15.4514 |
| 19 February, 2026 | 15.449 |
| 18 February, 2026 | 15.597 |
| 17 February, 2026 | 15.5775 |
| 16 February, 2026 | 15.3469 |
| 13 February, 2026 | 15.3267 |
| 12 February, 2026 | 15.5588 |
| 11 February, 2026 | 15.4867 |
| 10 February, 2026 | 15.2893 |
| 9 February, 2026 | 15.2537 |
| 6 February, 2026 | 15.023 |
| 5 February, 2026 | 15.0242 |
| 4 February, 2026 | 15.1176 |
| 3 February, 2026 | 15.1336 |
| 2 February, 2026 | 14.7868 |
| 30 January, 2026 | 14.9626 |
| 29 January, 2026 | 14.7581 |
| 28 January, 2026 | 14.7625 |
| 27 January, 2026 | 14.6224 |
| 23 January, 2026 | 14.6304 |
| 22 January, 2026 | 14.8391 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of quant Healthcare Fund - Growth Option - Direct Plan?
The latest NAV of quant Healthcare Fund - Growth Option - Direct Plan is 15.2494 as on 6 March, 2026.
What are YTD (year to date) returns of quant Healthcare Fund - Growth Option - Direct Plan?
The YTD (year to date) returns of quant Healthcare Fund - Growth Option - Direct Plan are -2.1% as on 6 March, 2026.
What are 1 year returns of quant Healthcare Fund - Growth Option - Direct Plan?
The 1 year returns of quant Healthcare Fund - Growth Option - Direct Plan are 7.96% as on 6 March, 2026.